臨床試験イメージング市場：製品・サービス、モダリティ、治療分野、エンドユーザー別-2025-2030年世界予測

臨床試験イメージング市場は、2023年に13億1,000万米ドルと評価され、2024年には13億9,000万米ドル、CAGR 6.68%で成長し、2030年には20億6,000万米ドルに達すると予測されています。

臨床試験画像は、近代的な臨床研究に不可欠な要素として登場し、変革的な成長を遂げています。このイントロダクションでは、技術革新、規制の進展、精密診断に対する需要の高まりが相互に作用していることを強調しながら、市場力学の概要を紹介します。近年、画像診断は補助的な役割を超え、臨床試験における戦略的意思決定の原動力となっています。先進的な画像技術を活用することで、研究機関はリアルタイムで洞察を得、患者募集を加速し、より正確な試験結果を確保できるようになりました。

臨床試験画像の進化は、データ主導の戦略と高度な可視化技術が極めて重要であるヘルスケアにおける広範な動向を反映しています。利害関係者が臨床試験デザイン、リスク管理、業務効率の最適化を目指す中、画像ソリューションは不可欠なものとなりつつあります。本レポートでは、市場の動向、課題、将来の機会について詳細な展望を示すとともに、最先端のイメージングサービスの統合が臨床試験プロセスをどのように変革するかを概説します。本レポートは、革新的なイメージング技術によって臨床試験の有効性を高める意思決定者、業界専門家、利害関係者を対象としています。

臨床試験イメージングの情勢における変革的変化

ここ数年、臨床試験のイメージング状況は、急速な技術進歩や規制枠組みの進化によって大きな変化を遂げています。人工知能、機械学習、ビッグデータ解析の進歩は、画像取得、保存、解析のプロセスを再定義し、より迅速な納期とより確実なデータ解釈をもたらしました。この進化は単なるデジタル変革の問題ではなく、複雑化する最新の臨床試験に対応するための戦略的方向転換です。

臨床試験の利害関係者は、精度と業務効率を向上させるテクノロジーをますます採用するようになっています。リアルタイムのデータ処理、画質の向上、スケーラブルな解析プラットフォームといった重要な側面が、重要な意思決定を行うための画像データの活用方法を再形成しています。高度に規制された環境と迅速なタイムラインへのプレッシャーの要求に対応するため、先進的な画像処理ソリューションの統合は、コンプライアンスを確保し、患者の安全性とデータの完全性を最高水準に維持する上で極めて重要な役割を担っています。このシフトは、オペレーションの卓越性と強固な規制遵守の両方を提供するツールを採用することで、臨床研究における将来の課題に適応できる強靭なフレームワークを構築する戦略的な動きを反映しています。

臨床試験イメージング市場の主なセグメンテーション洞察

臨床試験イメージング市場のセグメンテーション分析から、多様な技術的、臨床的、業務的ニーズに対応する複雑で多層的な構造が明らかになりました。市場セグメンテーションでは、まず製品・サービス別に市場を分類し、サービスおよびソフトウェアに焦点を当てる。サービスはさらに、オペレーショナル・イメージング・サービス、リード・アナリシス・サービス、システム＆テクニカル・サポート・サービス、トライアル・デザイン＆コンサルティング・サービスなどの専門的なサービスに分類され、包括的でカスタマイズ可能なソリューションを提供しようとする業界の努力が示されています。

サービスの方向性だけでなく、市場はモダリティ（CT、心エコー、磁気共鳴画像、陽電子放射断層撮影、超音波、X線）別にも区分されています。このセグメンテーションは、各臨床ニーズに最も適した技術によって臨床試験が確実にサポートされるようにするためのモダリティの多様性の重要性を強調するものです。内分泌学、免疫疾患、感染症、神経学、腫瘍学を含む治療領域別の層別化は、各疾患特有の診断とモニタリングの必要条件を満たすための戦略を反映しています。患者中心のモダリティとともに、エンドユーザーに基づくセグメンテーションは重要な役割を果たし、市場を学術・政府研究機関、バイオテクノロジー企業、受託研究機関、製薬会社に分類しています。このように細分化された洞察は、市場が幅広い臨床需要に対応することで、複雑な治療領域における精度、効率、治療成績の向上に取り組んでいることを示しています。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で慢性疾患とがんの罹患率が増加
    • 高度な画像技術の導入による精密医療の重要性の高まり
  • 抑制要因
    • 画像技術に関連する高コストと熟練した人材の不足
  • 機会
    • エラーを最小限に抑え、効率を最大化するための人工知能（AI）の統合
    • 臨床試験イメージング技術の拡大に向けた投資と資金の増加
  • 課題
    • 臨床試験イメージングにおけるプライバシーと同意に関する倫理的懸念
• 市場セグメンテーション分析
  • 製品とサービス：臨床試験イメージングサービス提供の進歩
  • モダリティ：迅速な画像化能力と詳細な断面画像が得られるため、コンピュータ断層撮影法が好まれる傾向が高まっています。
  • 治療領域：多様な治療領域における臨床試験イメージングの中心的な役割とその進化する応用
  • エンドユーザー：学術機関および政府調査機関における臨床試験イメージングの需要増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 臨床試験イメージング市場：製品・サービス別

• サービス
  • 運用イメージングサービス
  • 分析サービスを読む
  • システムおよび技術サポートサービス
  • 試験設計およびコンサルティングサービス
• ソフトウェア

第7章 臨床試験イメージング市場：モダリティ別

• コンピュータ断層撮影
• 心エコー検査
• 磁気共鳴画像法
• 陽電子放出断層撮影
• 超音波
• X線

第8章 臨床試験イメージング市場治療領域別

• 内分泌学
• 免疫疾患
• 感染症
• 神経学
• 腫瘍学

第9章 臨床試験イメージング市場：エンドユーザー別

• 学術機関および政府調査機関
• バイオテクノロジー企業
• 契約調査機関
• 製薬会社

第10章 南北アメリカの臨床試験イメージング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の臨床試験イメージング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの臨床試験イメージング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析, 2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Alimentiv Inc.
• Anagram 4 Clinical Trials
• Biospective Inc.
• Boston Imaging Core Lab LLC
• Cardiovascular Imaging Technologies LLC
• Clario
• GE HealthCare Technologies Inc.
• Icon PLC
• Image Core Lab Private Limited
• Imaging Endpoints II LLC
• Ixico PLC
• Median Technologies
• Medical Metrics Inc. by Catalent, Inc.
• Medidata by Dassault Systemes
• Medpace, Inc.
• Micron Inc.
• Perceptive Informatics LLC
• ProScan Imaging LLC
• Resonance Health Ltd.
• Voiant Clinical
• WCG Clinical, Inc.

LIST OF FIGURES

• FIGURE 1. CLINICAL TRIAL IMAGING MARKET MULTI-CURRENCY
• FIGURE 2. CLINICAL TRIAL IMAGING MARKET MULTI-LANGUAGE
• FIGURE 3. CLINICAL TRIAL IMAGING MARKET RESEARCH PROCESS
• FIGURE 4. CLINICAL TRIAL IMAGING MARKET SIZE, 2023 VS 2030
• FIGURE 5. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. CLINICAL TRIAL IMAGING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. CLINICAL TRIAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CLINICAL TRIAL IMAGING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CLINICAL TRIAL IMAGING MARKET DYNAMICS
• TABLE 7. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY OPERATIONAL IMAGING SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY READ ANALYSIS SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY SYSTEM & TECHNICAL SUPPORT SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY TRIAL DESIGN & CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ECHOCARDIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY X-RAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY IMMUNOLOGICAL DISORDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. CANADA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 50. CANADA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 51. CANADA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 52. CANADA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 53. CANADA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. CHINA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 77. CHINA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 78. CHINA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 79. CHINA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 80. CHINA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. INDIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 82. INDIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 83. INDIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 84. INDIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 85. INDIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 88. INDONESIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 89. INDONESIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 90. INDONESIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 93. JAPAN CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 94. JAPAN CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 95. JAPAN CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 97. MALAYSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 98. MALAYSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 99. MALAYSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 100. MALAYSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 102. PHILIPPINES CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 103. PHILIPPINES CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 104. PHILIPPINES CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 105. PHILIPPINES CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 107. SINGAPORE CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 108. SINGAPORE CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 109. SINGAPORE CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 110. SINGAPORE CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 112. SOUTH KOREA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 113. SOUTH KOREA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 114. SOUTH KOREA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 115. SOUTH KOREA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 117. TAIWAN CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 118. TAIWAN CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 119. TAIWAN CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 120. TAIWAN CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 122. THAILAND CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 123. THAILAND CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 124. THAILAND CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 125. THAILAND CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 127. VIETNAM CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 128. VIETNAM CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 129. VIETNAM CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 130. VIETNAM CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 135. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 138. DENMARK CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 139. DENMARK CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 140. DENMARK CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 141. DENMARK CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 143. EGYPT CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 144. EGYPT CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 145. EGYPT CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 146. EGYPT CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 148. FINLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 149. FINLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 150. FINLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 151. FINLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 153. FRANCE CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 154. FRANCE CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 155. FRANCE CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 156. FRANCE CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 158. GERMANY CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 159. GERMANY CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 160. GERMANY CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 161. GERMANY CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 163. ISRAEL CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 164. ISRAEL CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 165. ISRAEL CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 166. ISRAEL CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. ITALY CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 168. ITALY CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 169. ITALY CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 170. ITALY CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 171. ITALY CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 173. NETHERLANDS CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 174. NETHERLANDS CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 175. NETHERLANDS CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 176. NETHERLANDS CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 178. NIGERIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 179. NIGERIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 180. NIGERIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 181. NIGERIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 183. NORWAY CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 184. NORWAY CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 185. NORWAY CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 186. NORWAY CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. POLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 188. POLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 189. POLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 190. POLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 191. POLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 192. QATAR CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 193. QATAR CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 194. QATAR CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 195. QATAR CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 196. QATAR CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 198. RUSSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 199. RUSSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 200. RUSSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 201. RUSSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 203. SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 204. SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 205. SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 206. SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 209. SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 210. SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 211. SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 213. SPAIN CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 214. SPAIN CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 215. SPAIN CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 216. SPAIN CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 218. SWEDEN CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 219. SWEDEN CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 220. SWEDEN CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 221. SWEDEN CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 223. SWITZERLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 224. SWITZERLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 225. SWITZERLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 226. SWITZERLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 228. TURKEY CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 229. TURKEY CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 230. TURKEY CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 231. TURKEY CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 233. UNITED ARAB EMIRATES CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 234. UNITED ARAB EMIRATES CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 235. UNITED ARAB EMIRATES CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 236. UNITED ARAB EMIRATES CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 238. UNITED KINGDOM CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 239. UNITED KINGDOM CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 240. UNITED KINGDOM CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 241. UNITED KINGDOM CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 242. CLINICAL TRIAL IMAGING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 243. CLINICAL TRIAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2023

The Clinical Trial Imaging Market was valued at USD 1.31 billion in 2023 and is projected to grow to USD 1.39 billion in 2024, with a CAGR of 6.68%, reaching USD 2.06 billion by 2030.

Clinical trial imaging has undergone transformative growth, emerging as a vital component in the landscape of modern clinical research. This introductory section presents an overview of the market dynamics, emphasizing the interplay of technological innovations, regulatory progress, and the increasing demand for precision diagnostics. In recent years, imaging has moved beyond a supportive role and has become a driver of strategic decision-making in clinical trials. By leveraging advanced imaging technologies, research organizations can now obtain real-time insights, accelerate patient recruitment, and ensure more accurate trial outcomes.

The evolution of clinical trial imaging reflects the broader trends in healthcare, where data-driven strategies and enhanced visualization techniques are pivotal. As stakeholders seek to optimize trial design, risk management, and operational efficiency, imaging solutions are becoming indispensable. This report provides an in-depth perspective on market trends, challenges, and future opportunities while outlining how the integration of cutting-edge imaging services transforms the clinical trial process. The insights discussed here cater to decision-makers, industry experts, and stakeholders committed to enhancing trial efficacy through innovative imaging technologies.

Transformative Shifts in the Landscape of Clinical Trial Imaging

Over recent years, the clinical trial imaging landscape has witnessed significant transformations driven by rapid technological advancements and evolving regulatory frameworks. Uplifts in artificial intelligence, machine learning, and big data analytics have redefined the process of image acquisition, storage, and analysis, leading to faster turnaround times and more robust data interpretation. This evolution is not merely a matter of digital transformation; it is a strategic reorientation to meet the growing complexity of modern clinical trials.

Stakeholders in clinical trials are increasingly embracing technologies that enhance precision and operational efficiency. Crucial dimensions such as real-time data processing, improved image quality, and scalable analysis platforms have re-shaped how imaging data is utilized to make critical decisions. As organizations align with the demands of highly regulated environments and pressure for accelerated timelines, the integration of advanced imaging solutions plays a pivotal role in ensuring compliance and maintaining the highest standards of patient safety and data integrity. This shift reflects a strategic move towards embracing tools that offer both operational excellence and robust regulatory compliance, thereby creating a resilient framework that can adapt to future challenges in clinical research.

Key Segmentation Insights in the Clinical Trial Imaging Market

The segmentation analysis of the clinical trial imaging market reveals a complex and multilayered structure that accommodates diverse technological, clinical, and operational needs. Adopting a segmented approach, the market is initially categorized based on Product & Service, where the focus lies on both Services and Software. Services further break down into specialized offerings such as Operational Imaging Services, Read Analysis Services, System & Technical Support Services, and Trial Design & Consulting Services, showcasing an industry effort to deliver comprehensive and customizable solutions.

Beyond service orientation, the market is also segmented by Modality, an approach that includes Computed Tomography, Echocardiography, Magnetic Resonance Imaging, Positron Emission Tomography, Ultrasound, and X-Ray. This segmentation underscores the importance of modality diversity in ensuring trials are supported by the most appropriate technology for each clinical need. Further stratification by Therapeutic Area - encompassing Endocrinology, Immunological Disorder, Infectious Diseases, Neurology, and Oncology - reflects tailored strategies that meet condition-specific diagnostic and monitoring requirements. In conjunction with patient-centric modalities, segmentation based on End-User plays a vital role, categorizing the market across academic and government research institutes, biotechnology companies, contract research organizations, and pharmaceutical companies. Together, these segmented insights demonstrate the market's commitment to addressing a broad spectrum of clinical demands, thereby ensuring precision, efficiency, and enhanced outcomes in complex therapeutic areas.

Based on Product & Service, market is studied across Services and Software. The Services is further studied across Operational Imaging Services, Read Analysis Services, System & Technical Support Services, and Trial Design & Consulting Services.

Based on Modality, market is studied across Computed Tomography, Echocardiography, Magnetic Resonance Imaging, Positron Emission Tomography, Ultrasound, and X-Ray.

Based on Therapeutic area, market is studied across Endocrinology, Immunological Disorder, Infectious Diseases, Neurology, and Oncology.

Based on End-User, market is studied across Academic & Government Research Institutes, Biotechnology Companies, Contract Research Organizations, and Pharmaceutical Companies.

Key Regional Insights across Global Clinical Trial Imaging Markets

Global trends in clinical trial imaging are notably influenced by regional variations that determine market maturity, regulatory landscapes, and technological adoption rates. In the Americas, robust investments in healthcare infrastructure coupled with advanced regulatory systems have fostered an environment that supports innovative imaging methodologies. The region's focus on reducing trial timelines and increasing diagnostic accuracy has driven significant investments in both hardware and software innovations, ensuring that imaging serves as a cornerstone for clinical decision-making.

In the Europe, Middle East & Africa region, the market exhibits a dynamic blend of tradition and modernity. European countries continue to maintain high standards in clinical research, supported by a history of stringent regulatory oversight, while the Middle East & Africa are rapidly emerging as competitive surrogates in clinical trials, driven by increasing investments and a growing demand for sophisticated imaging services. The diverse cultural, economic, and political backdrop across these regions encourages a nuanced approach to imaging solutions that cater to distinct market needs and regulatory environments.

Meanwhile, the Asia-Pacific region has experienced exponential growth, propelled by the rise of biotechnology hubs and expanding healthcare markets. This region benefits from cost efficiencies, an expanding talent pool, and a rapid embracement of technological innovations which, together, have significantly bolstered its position in the global clinical trial imaging market. Comprehensive strategies in these regions illustrate how localized elements drive the overall market trends, offering insightful perspectives on how innovations and regulatory harmonization are shaping the future of clinical research worldwide.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Steering Innovation in Clinical Trial Imaging

The clinical trial imaging market is reinforced by the presence of several influential companies that are at the forefront of technological innovation and service delivery. Leading players like Alimentiv Inc., Anagram 4 Clinical Trials, Biospective Inc., and Boston Imaging Core Lab LLC contribute robustly with tailored imaging solutions that streamline trial operations. Companies such as Cardiovascular Imaging Technologies LLC and Clario have consistently introduced enhanced diagnostic capabilities that ensure faster and more accurate image assessments.

Furthermore, GE HealthCare Technologies Inc. and Icon PLC have built their reputations on delivering state-of-the-art technologies that push the limits of what is achievable in clinical imaging. Image Core Lab Private Limited and Imaging Endpoints II LLC have expanded the horizons of imaging analysis through their sophisticated hardware and software integrations, while Ixico PLC continues to leverage innovative analytical methods to support trial decision-making processes. In addition, Median Technologies and Medical Metrics Inc. by Catalent, Inc. stand out for offering comprehensive services that integrate both operational expertise and technological advancements.

The market is further enriched by the contributions of Medidata by Dassault Systemes and Medpace, Inc., whose analytics-driven approaches optimize both trial operational management and data accuracy. Micron Inc. and Perceptive Informatics LLC have capitalized on emerging technological trends to streamline imaging workflows, with ProScan Imaging LLC and Resonance Health Ltd. following suit by focusing on high-quality imaging outputs. The pivotal roles of Voiant Clinical and WCG Clinical, Inc. further underscore the market's competitive edge, driving evolution through collaborative initiatives and innovative practices. Collectively, these companies exemplify the drive towards operational excellence and technological proficiency in the domain of clinical trial imaging.

The report delves into recent significant developments in the Clinical Trial Imaging Market, highlighting leading vendors and their innovative profiles. These include Alimentiv Inc., Anagram 4 Clinical Trials, Biospective Inc., Boston Imaging Core Lab LLC, Cardiovascular Imaging Technologies LLC, Clario, GE HealthCare Technologies Inc., Icon PLC, Image Core Lab Private Limited, Imaging Endpoints II LLC, Ixico PLC, Median Technologies, Medical Metrics Inc. by Catalent, Inc., Medidata by Dassault Systemes, Medpace, Inc., Micron Inc., Perceptive Informatics LLC, ProScan Imaging LLC, Resonance Health Ltd., Voiant Clinical, and WCG Clinical, Inc.. Actionable Recommendations for Industry Leaders

To remain competitive in this dynamic market, industry leaders should prioritize investments in advanced imaging technology and data analytics, which are fundamental to improving trial efficiency and accuracy. Formulating strategic partnerships that integrate operational imaging services with cutting-edge software solutions is essential. Leaders are encouraged to focus on customizing imaging solutions aligned with therapy-specific needs and regional regulatory requirements. Additionally, scaling digital transformation initiatives and ensuring robust data security protocols will aid in navigating the complexities of modern clinical trials, ensuring both quality and operational agility. These actions collectively will streamline workflows and enhance competitive positioning.

Conclusion and Future Outlook

The clinical trial imaging market is in a state of continuous evolution, driven by technological breakthroughs, diversified segmentation strategies, and expanding global footprints. The multifaceted analysis presented in this report and the discussions on modality-specific, therapeutic, and end-user oriented segmentation reinforce the market's multidimensional nature. As industry players strategically position themselves to meet ever-increasing demands for accuracy and efficiency, it is evident that clinical trial imaging will remain a cornerstone of successful research endeavors. The integration of advanced imaging methods in clinical trials not only bolsters compliance and operational excellence but also paves the way for groundbreaking therapeutic advancements. The future of clinical trial imaging promises enhanced data integration, stronger global collaborations, and sustained innovation, ensuring that stakeholders can confidently steer through an increasingly complex research environment.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of chronic diseases and cancer worldwide
    • 5.1.1.2. Increasing emphasis on precision medicine for the adoption of advanced imaging techniques
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with the imaging techniques and shortage of skilled personnel
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of artificial intelligence (AI) to minimize errors and maximize efficiency
    • 5.1.3.2. Increasing investments and funding for the expansion of clinical trial imaging technology
  • 5.1.4. Challenges
    • 5.1.4.1. Ethical concerns around privacy and consent in clinical trial imaging
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product & Service: Increasing advancements in clinical trial imaging service offerings
  • 5.2.2. Modality: Growing preference for computed tomography for quick imaging capability and detailed cross-sectional views
  • 5.2.3. Therapeutic area: Pivotal role of clinical trial imaging across diverse therapeutic areas and its evolving applications
  • 5.2.4. End-User: Rising demand of clinical trial imaging in academic & government research institutes
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Clinical Trial Imaging Market, by Product & Service

• 6.1. Introduction
• 6.2. Services
  • 6.2.1. Operational Imaging Services
  • 6.2.2. Read Analysis Services
  • 6.2.3. System & Technical Support Services
  • 6.2.4. Trial Design & Consulting Services
• 6.3. Software

7. Clinical Trial Imaging Market, by Modality

• 7.1. Introduction
• 7.2. Computed Tomography
• 7.3. Echocardiography
• 7.4. Magnetic Resonance Imaging
• 7.5. Positron Emission Tomography
• 7.6. Ultrasound
• 7.7. X-Ray

8. Clinical Trial Imaging Market, by Therapeutic area

• 8.1. Introduction
• 8.2. Endocrinology
• 8.3. Immunological Disorder
• 8.4. Infectious Diseases
• 8.5. Neurology
• 8.6. Oncology

9. Clinical Trial Imaging Market, by End-User

• 9.1. Introduction
• 9.2. Academic & Government Research Institutes
• 9.3. Biotechnology Companies
• 9.4. Contract Research Organizations
• 9.5. Pharmaceutical Companies

10. Americas Clinical Trial Imaging Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Clinical Trial Imaging Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Clinical Trial Imaging Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. DeepHealth partners with HOPPR to revolutionize cancer detection with advanced AI imaging models
  • 13.3.2. Subtle Medical revolutionizes clinical imaging with NIH-funded AI tech for enhanced brain MRI efficiency
  • 13.3.3. GE HealthCare's strategic acquisition to enhance AI capabilities in ultrasound imaging precision
  • 13.3.4. Strategic partnership between Voiant and Thirona to revolutionize AI imaging in pulmonary clinical trials
  • 13.3.5. RapidAI's expansion into Japan marks a significant milestone in clinical trial imaging innovation
  • 13.3.6. Aidoc invests USD 30 million to advance comprehensive AI models revolutionizing precision in medical imaging
  • 13.3.7. Altis Labs' global initiative using AI digital twins to transform cancer clinical trial design
  • 13.3.8. WCG partners with Mint Medical to revolutionize imaging workflows in oncology clinical trials for enhanced data precision
  • 13.3.9. Clario introduces a cloud-based image viewer for real-time data access
• 13.4. Strategy Analysis & Recommendation
  • 13.4.1. Clario
  • 13.4.2. WCG Clinical, Inc.
  • 13.4.3. Ixico PLC
  • 13.4.4. Icon PLC

Companies Mentioned

• 1. Alimentiv Inc.
• 2. Anagram 4 Clinical Trials
• 3. Biospective Inc.
• 4. Boston Imaging Core Lab LLC
• 5. Cardiovascular Imaging Technologies LLC
• 6. Clario
• 7. GE HealthCare Technologies Inc.
• 8. Icon PLC
• 9. Image Core Lab Private Limited
• 10. Imaging Endpoints II LLC
• 11. Ixico PLC
• 12. Median Technologies
• 13. Medical Metrics Inc. by Catalent, Inc.
• 14. Medidata by Dassault Systemes
• 15. Medpace, Inc.
• 16. Micron Inc.
• 17. Perceptive Informatics LLC
• 18. ProScan Imaging LLC
• 19. Resonance Health Ltd.
• 20. Voiant Clinical
• 21. WCG Clinical, Inc.